CrossRef Text and Data Mining

Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.

Clinical Outcome in Cases of Viral Breakthrough During Lamivudine Therapy in Chronic Hepatitis B Patients

Clin Mol Hepatol. 2002;8(4):389-396. Published online 1970 January 1

Viral Breakthrough during Lamivudine Therapy for Chronic Hepatitis B

Nancy Leung

Intervirology. 2003;46(6):344-349

Link1 Link2

425 Lowest serum hepatitis B virus DNA level is predicable factor for viral breakthrough during lamivudine therapy in chronic hepatitis B patients

M. Cho, J. Heo, D.Y. Lyu, B.M. Cho, H.H. Kim, G.H. Kim, D.H. Kang, G.A. Song, U.S. Yang

Journal of Hepatology. 2004;40:126

Link1 Link2

Viral dynamics in chronic hepatitis B patients during lamivudine therapy

LMM Wolters, BE Hansen, HGM Niesters, S Zeuzem, SW Schalm, Man. RA de, Lonieke M. M. Wolters, Bettina E. Hansen, Hubert G. M. Niesters, Stefan Zeuzem, Solko W. Schalm, Robert A. De Man

Liver. 2002;22(2):121-126

Link1 Link2 Link3

Clinical course of patients with chronic hepatitis B with viral breakthrough during long-term lamivudine treatment

Tatsuya Ide, Ryukichi Kumashiro, Reiichiro Kuwahara, Hiroyuki Koga, Yuriko Koga, Teruko Hino, Kazuo Tanaka, Akiko Hisamochi, Kei Ogata, Michio Sata

Journal of Gastroenterology. 2005;40(6):625-630

Link1

Link2 Link3

Remission of breakthrough hepatitis in chronic hepatitis B patients on lamivudine

Kazuhiko Koike

Journal of Gastroenterology. 2002;37(11):988-990

Link1

Link2 Link3

Hepatitis B surface antigen seroconversion is associated with favourable long-term clinical outcomes during lamivudine treatment in HBeAg-negative chronic hepatitis B patients

R. Idilman, K. Cinar, G. Seven, Y. Bozkus, A. Elhan, M. Bozdayi, C. Yurdaydin, K. Bahar

Journal of Viral Hepatitis. 2011;19(3):220-226

Link1 Link2

470 HBeAg negative patients with chronic hepatitis B are less likely to have A biochemical breakthrough during lamivudine treatment

Journal of Hepatology. 2005;42:170

Link1 Link2

Hepatitis B virus variants in patients receiving lamivudine treatment with breakthrough hepatitis evaluated by serial viral loads and full-length viral sequences

C Liu

Hepatology. 2001;34(3):583-589

Link1 Link2

Entecavir/lamivudine/tenofovir disoproxil fumarate

Reactions Weekly. 2017;1657(1):178-178

Link1

Link2 Link3

1178 Effect of the precore mutations on the HBEAG loss and viral breakthrough during lamivudine therapy in HBEAG-positive chronic hepatitis B

S KIM, Y HWANG, K KWON, M JUNG, D PARK, O KWON, S KWON, Y KIM, Y KOO, Y KIM

Hepatology. 2003;38:723-723

Link1 Link2

This metadata service is kindly provided by CrossRef from May 29, 2014. Clin Mol Hepatol has participated in CrossRef Text and Data Mining service since March 1, 2015.